These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2429459)

  • 1. [The treatment of premature heart beats in children and adolescents].
    Baszyński J; Sysowa V; Sordyl E; Karpiński E; Szydłowski A; Sobuś W; Jackowski W; Erenbek M; Sakson B
    Wiad Lek; 1986 May; 39(10):649-55. PubMed ID: 2429459
    [No Abstract]   [Full Text] [Related]  

  • 2. Does treatment of ventricular premature beats prevent sudden cardiac death?
    Whitlock RR
    J Med Assoc Ga; 1983 Dec; 72(12):859-61. PubMed ID: 6198415
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacodynamics and pharmacokinetics of loracainide, a new anti-arrhythmia agent].
    Meinertz T; Kasper W; Kersting F; Just H; Jähnchen E
    Verh Dtsch Ges Inn Med; 1978; (84):1477-9. PubMed ID: 84447
    [No Abstract]   [Full Text] [Related]  

  • 4. Encainide for cardiac arrhythmias.
    Med Lett Drugs Ther; 1987 May; 29(740):50-2. PubMed ID: 2437434
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of oral pirmenol in suppressing ventricular premature depolarisations.
    de Buitleir M; Crevey B; Johnson T; Baerman J; Morady F
    Ir Med J; 1987 Feb; 80(2):60-3. PubMed ID: 2435676
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of anti-arrhythmia agents].
    Klein G; Wirtzfeld A; Schlegl J; Himmler C; Neiss A
    Med Klin; 1980 Nov; 75(24):853-5. PubMed ID: 6160379
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of the anti-arrhythmia effect of trimecaine].
    Merzon AK; Doviner AD; Degtiar AN; Rodin IN; Rudenko NN
    Vrach Delo; 1983 May; (5):23-6. PubMed ID: 6192593
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative effectiveness of neogilurytmal, novocainamide, ethmozin, disopyramide and ethacizin in supraventricular extrasystole].
    Shpektor AV; Gorshkov VA; Mamaev VI; Sherashov VS; Kurakina TI
    Sov Med; 1986; (12):96-7. PubMed ID: 2436318
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical studies with propafenone--a new antiarrhythmic agent.
    Prabhakaran SN; Bhatia ML
    Indian Heart J; 1984; 36(2):107-10. PubMed ID: 6202621
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of tachycardiac arrhythmias in infants and children using Isoptin].
    Bühlmeyer K; Lang-Krebs T
    Med Klin; 1969 Dec; 64(52):2410-3. PubMed ID: 4191748
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of chronic ventricular extrasystole with propafenone (Rhythmonorm)].
    Dimitrov D
    Vutr Boles; 1984; 23(4):65-9. PubMed ID: 6209861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of chronic ventricular extrasystole].
    Davy JM; Sirinelli A; Le Guludec D; Sebag C; Motté G
    Rev Prat; 1986 Nov; 36(53):3138-46. PubMed ID: 2433731
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of premature ventricular contractions.
    Kessler KM; Chakko CS; Myerburg RJ
    Heart Dis Stroke; 1992; 1(5):275-80. PubMed ID: 1285343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Verh Dtsch Ges Herz Kreislaufforsch; 1981; 47():18-33. PubMed ID: 6173967
    [No Abstract]   [Full Text] [Related]  

  • 15. [The need for treatment of extrasystole].
    Weber H
    Z Gesamte Inn Med; 1983 Jun; 38(12):84-7. PubMed ID: 6193652
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination therapy with anti-arrhythmia agents].
    Kettner W; Götze C
    Z Arztl Fortbild (Jena); 1986; 80(21):889-92. PubMed ID: 2436386
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tactics of treatment of patients with arrhythmia].
    Glezer MG; Orlov LL
    Klin Med (Mosk); 1995; 73(4):13-7. PubMed ID: 7474808
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new method for the evaluation of the success of anti-arrhythmic drug therapy and a paradoxical drug-induced arrhythmogenic effect in individual patients].
    Andresen D; von Leitner ER; Wegscheider K; Schröder R
    Z Kardiol; 1984 Aug; 73(8):492-7. PubMed ID: 6208699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premature ventricular complexes and ventricular tachycardia: long-term perspective for prognosis and treatment.
    Anderson JL
    Trans Assoc Life Insur Med Dir Am; 1988; 71():27-35. PubMed ID: 2453094
    [No Abstract]   [Full Text] [Related]  

  • 20. [Which first-choice anti-arrhythmia agent would you use in ventricular extrasystoles following myocardial infarct?].
    Med Welt; 1981 Jun; 32(24):979-80. PubMed ID: 6166827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.